The Cardioband transcatheter annular reduction system.

Ann Cardiothorac Surg 2018 Nov;7(6):741-747

Intermountain Heart Institute, Salt Lake City, UT, USA.

Surgical implantation of a complete or incomplete ring to reduce the mitral valve annulus and improve leaflet coaptation is the foundation of valve repair for degenerative and functional mitral and tricuspid regurgitation. The Cardioband system (Edwards Lifesciences, Irvine, CA, USA) is a catheter-delivered annular reduction system that mimics the surgical approach. Sequential anchors are used to secure the Cardioband implant from trigone to trigone. The Cardioband implant is contracted under transesophageal guidance until valvular regurgitation is reduced. In the initial clinical experience, the Cardioband system was safely deployed in patients with clinically significant functional mitral regurgitation (MR) and yielded durable MR reduction, improved quality of life, and improved exercise capacity. The early and still-evolving Cardioband experience for tricuspid regurgitation is also promising. The ongoing pivotal ACTIVE Trial is designed to demonstrate the superiority of the Cardioband system to guideline-directed medical therapy in patients with clinically significant functional MR (FMR) using a composite endpoint of mortality, heart failure (HF) hospitalization, quality of life, and exercise capacity.

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.10.10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288207PMC
November 2018
4 Reads

Publication Analysis

Top Keywords

cardioband system
12
clinically functional
8
reduction system
8
quality life
8
cardioband implant
8
patients clinically
8
annular reduction
8
exercise capacity
8
functional mitral
8
tricuspid regurgitation
8
cardioband
7
system
5
superiority cardioband
4
demonstrate superiority
4
valvular regurgitation
4
regurgitation reduced
4
guidance valvular
4
transesophageal guidance
4
implant contracted
4
contracted transesophageal
4

Similar Publications